6 ML radium chloride Ra-223 30 MCI/ML Injection — RxCUI 1424214
RxNorm drug concept · Semantic clinical drug
RxCUI 1424214
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1424214
Official name6 ML radium chloride Ra-223 30 MCI/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asradium Ra-223 dichloride 178 MCI per 6 ML Injection; radium Ra-223 1100 kBq/ML in 6 ML Injection; radium Ra-223 dichloride 6600 kBq per 6 ML Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How 6 ML radium chloride Ra-223 30 MCI/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
6 ML radium chloride Ra-223 30 MCI/ML Injection
RxCUI 1424214 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Radium
1546450IN -
Radium chloride Ra-223
1424174PIN
-
Radium
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Xofigo
1424215BN
-
Xofigo
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Radium Injection
2587439SCDF -
Radium chloride Ra-223 Injection
2647643SCDFP -
Radium Injectable Product
2587447SCDG -
Radium chloride Ra-223 Injectable Product
2660153SCDGP -
Radium Injection [Xofigo]
2587444SBDF -
Radium chloride Ra-223 Injection [Xofigo]
2658055SBDFP -
Xofigo Injectable Product
1424218SBDG -
Injection
1649574DF - +1 more in this family
-
Radium Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Radium chloride Ra-223 30 MCI/ML
1745391SCDC -
6 ML radium chloride Ra-223 30 MCI/ML Injection [Xofigo]
1424219SBD -
Radium chloride Ra-223 30 MCI/ML [Xofigo]
1745393SBDC
-
Radium chloride Ra-223 30 MCI/ML
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Radium chloride Ra-223 30 MCI/ML
SCDC · 1745391 -
Radium Injection
SCDF · 2587439 -
Radium chloride Ra-223 Injection
SCDFP · 2647643 -
Radium Injectable Product
SCDG · 2587447 -
Radium chloride Ra-223 Injectable Product
SCDGP · 2660153
Brand-Name Concepts
-
6 ML radium chloride Ra-223 30 MCI/ML Injection [Xofigo]
SBD · 1424219 -
Radium chloride Ra-223 30 MCI/ML [Xofigo]
SBDC · 1745393 -
Radium Injection [Xofigo]
SBDF · 2587444 -
Radium chloride Ra-223 Injection [Xofigo]
SBDFP · 2658055 -
Xofigo Injectable Product
SBDG · 1424218 -
Xofigo
BN · 1424215
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 1424214 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 50419-0208-01 | 6 mL in 1 VIAL, SINGLE-DOSE (50419-208-01) | Xofigo | Bayer HealthCare Pharmaceuticals Inc. | 2013-05-20 |
Observed labelers:
Bayer HealthCare Pharmaceuticals Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.